About
New Phase, is at the forefront of breakthrough solutions in Oncology. New Phase’s Nanotechnology System is a novel solution designed to treat metastatic solid tumors through delivery of thermal energy to malignant cells, thereby causing cancer cell death via electromagnetic hyperthermia, without harming healthy tissues and without side effects. Promising early feasibility studies show either tumor destruction or stable disease in patients that are already exhausted all other treatments.
New Phase technology can act as a stand-alone treatment, which aims to prolong the patient's life, with a chronic treatment which turn the disease to be manageable. This solution can be offered to stage IV patients either tried everything or would like an alternative approach instead of curable attempts which contain severe side effects
The technology involves two primary components developed by New Phase: Sarah Nanoparticles (SaNPs) and an Electromagnetic Induction System (EIS). The SaNPs are proprietary biocompatible nanoparticles containing multi core of super paramagnetic iron oxide. They are administered intravenously to the patient and localized via the Enhanced Permeability and Retention (EPR) effect on cancer cells. Following delivery and accumulation of the particles on malignant tissue, the patient undergoes regional body alternating magnetic field (AMF) application with the EIS at ~290 kHz. The SaNPs are activated by absorbing the AMF energy, converting it to thermal energy and reaching the desired temperature of 50°C. Cancer cells cannot survive at 50°C while healthy cells remain unharmed. As a result, this process leads to the destruction of malignant cells without causing damage to healthy cells.
Funding history · 1 round · $35.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is New Phase's primary therapeutic focus?
- New Phase is focused on developing breakthrough solutions in Oncology, specifically targeting metastatic solid tumors using a Nanotechnology System.
- How does New Phase's Nanotechnology System work to treat cancer?
- New Phase's Nanotechnology System delivers thermal energy to malignant cells via electromagnetic hyperthermia, causing cancer cell death without harming healthy tissues. This involves Sarah Nanoparticles (SaNPs) and an Electromagnetic Induction System (EIS).
- When was New Phase founded?
- New Phase was founded in August 2013.
- What is the current employee count for New Phase?
- New Phase has approximately 25 employees.
- What was New Phase's most recent funding round?
- New Phase completed a Series A funding round in December 2023, raising a total of $35,000,000.
- Has New Phase received any grants?
- Yes, New Phase received grants from the IIA in January 2024 and January 2023.
- What is the current product stage of New Phase's technology?
- New Phase's product is currently in the clinical trial stage.
- When did New Phase receive FDA approval for clinical trials in the U.S.?
- In June 2024, New Phase's cancer treatment received FDA approval for clinical trials in the U.S.
- When did New Phase begin human trials for its cancer treatment?
- New Phase began human trials for its cancer treatment in March 2022, aiming to prolong the lives of patients.